Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
104 |
issn |
1521-6926 |
issueIdentifier |
1 |
pageRange |
89-104 |
publicationName |
Best practice & research. Clinical haematology |
startingPage |
89 |
bibliographicCitation |
Bauer KA. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa. Best Practice & Research Clinical Haematology. 2004 Mar;17(1):89–104. doi: 10.1016/j.beha.2004.03.004. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_321f2c20426b8bf7d854da23e19a7da1 |
date |
200403 |
identifier |
https://doi.org/10.1016/j.beha.2004.03.004 https://pubmed.ncbi.nlm.nih.gov/15171960 |
isPartOf |
https://portal.issn.org/resource/ISSN/1521-6926 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22475 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Fondaparinux: a new synthetic and selective inhibitor of Factor Xa |
discusses |
http://id.nlm.nih.gov/mesh/M0017249 http://id.nlm.nih.gov/mesh/M0587609 http://id.nlm.nih.gov/mesh/M0403648 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011134Q000627 http://id.nlm.nih.gov/mesh/D065427 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D020246Q000517 http://id.nlm.nih.gov/mesh/D011183Q000517 http://id.nlm.nih.gov/mesh/D017202Q000188 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011134Q000493 http://id.nlm.nih.gov/mesh/D011134Q000494 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D020246Q000188 http://id.nlm.nih.gov/mesh/D019637Q000009 http://id.nlm.nih.gov/mesh/D000077425 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49852292 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49852403 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8026 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID636380 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11071 |